Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROCTER & GAMBLE Co Director's Dealing 2022

Dec 9, 2022

29757_dirs_2022-12-09_35dab083-6537-4cd1-a552-188a9242d923.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROCTER & GAMBLE Co (PG)
CIK: 0000080424
Period of Report: 2022-12-07

Reporting Person: Davis Jennifer L. (CEO - Health Care)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-12-07 Common Stock M 37.4691 $149.18 Acquired 39786.6054 Direct
2022-12-07 Common Stock F 37.4691 $149.18 Disposed 39749.1363 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-11-15 Restricted Stock Units $ A 13.086 Acquired Common Stock (13.086) Direct
2022-12-07 Restricted Stock Units $ M 37.4691 Disposed Common Stock (37.4691) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 12940.6033 Indirect

Footnotes

F1: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.

F2: Shares withheld to cover taxes on previous Restricted Stock Unit grant.

F3: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.

F4: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

F5: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2022.